Company: PHAT
Filing Date: 2025-08-07
Form Type: 8-K
Source: 0001193125-25-174943
Chunk: 1

Company: Phathom Pharmaceuticals, Inc.
Filing Date: 2025-08-07
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

  Exhibit      Description                                                                  
      No.                                                                                   
     99.1      Press Release issued on August 7, 2025                                       
 ────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                            PHATHOM PHARMACEUTICALS, INC.                                           
  Date: August 7, 2025      By:                                /s/ Steven Basta                     
                                                               Steven Basta                         
                                                               President & Chief Executive Officer